Back to Results
First PageMeta Content
Genetics / MicroRNA / Oncogenes / RNA / Mir-205 / Trastuzumab / Epidermal growth factor receptor / Breast cancer / HER2/neu / Biology / Medicine / Tyrosine kinase receptors


Functional cooperation of miR-125a, miR-125b, and miR-205 in entinostat-induced downregulation of erbB2/erbB3 and apoptosis in breast cancer cells
Add to Reading List

Document Date: 2013-03-21 11:00:58


Open Document

File Size: 1,88 MB

Share Result on Facebook

City

Fuzhou / Davidson / Valencia / Tianjin / Indianapolis / Hynes / Fremont / Foster City / Gibbstown / Chicago / St. Louis / /

Company

Roche Diagnostics Corp. / Cell Signaling Technology Inc. / EMD Chemicals Inc. / Dharmacon Inc. / Thermo Fisher Scientific Inc. / GE Healthcare Bio-Sciences Corp. / Sigma Co. / Bio-Rad Laboratories / QIAGEN Inc. / Syndax Pharmaceuticals Inc. / 3State Key Laboratory / Bio-Rad / LabVision Corp. / 2Fujian Key Laboratory / Macmillan Publishers Limited / State Key Laboratory / /

Country

United States / China / /

Currency

pence / /

/

Facility

Peking Union Medical College / Montrose Memorial Hospital / Blood Disease Hospital / University of Colorado Anschutz Medical Campus / Fuzhou General Hospital / Key Laboratory of Transplant Biology / Key Laboratory of Experimental Hematology / Institute of Hematology / State Key Laboratory of Experimental Hematology / /

IndustryTerm

miRNA networks / cancer therapy / cancer treatment / treatment of breast cancer / /

MedicalCondition

mouse mammary tumor / JE / castration-resistant prostate cancer / receptor-positive and triplenegative breast cancer / human epithelial ovarian cancer / solid tumors / human cancers / erbB2-overexpressing breast cancer / neuroblastoma / J Cancer / metastatic disease / ER-negative tumors / aggressive erbB2-overexpressing breast cancers / breast carcinomas / In breast cancers / breast tumor / Prostate Cancer / human breast cancer / breast cancer / breast carcinoma / Cancer The erbB receptor tyrosine kinase / cancers / tumor / mouse breast/mammary cancer / breast cancers / cancer / tumors / Disease / trastuzumab-resistant breast cancer / HER2-amplified breast cancer / human cancer / Clin Exp Metastasis / BT474 breast cancer / hematologic malignancies / malignant disease / erbB2-overexpressing tumors / erbB2-induced breast cancer / tumor necrosis / invasive breast cancer / human breast cancers / mammary tumor / /

MedicalTreatment

cancer therapy / anticancer therapies / /

Organization

Montrose Memorial Hospital / Department of Pathology / Blood Disease Hospital / School of Medicine / Department of Medicine / Fuzhou General Hospital / San Juan Cancer Center / Medical Sciences and Peking Union Medical College / University of Colorado Anschutz Medical Campus / Cancer League of Colorado / Chinese Academy of Medical Sciences / Hematology and Blood Disease Hospital / Institute of Hematology / /

Person

Dihua Yu / Van Peer / Beato M. Moderate / Lisa Litzenberger / Lee SR / Peter Ordentlich / Johnson C. Histone / /

Position

RT / messenger / Kang HB / USA *Corresponding author / representative / /

Product

Herceptin / F-12 / letrozole / paclitaxel / Taxol / /

ProvinceOrState

Aurora / South Dakota / Fujian / Colorado / /

RadioStation

Brodie AM / /

Technology

alpha / antibodies / apoptosis / gene expression / treating cancer / gel electrophoresis / /

URL

http /

SocialTag